Screening system for epidermal growth factor receptor mutation detection in cytology cell‐freeDNAof cerebrospinal fluid based on assured sample quality-Reference-Cited by-同舟云学术

Screening system for epidermal growth factor receptor mutation detection in cytology cell‐freeDNAof cerebrospinal fluid based on assured sample quality

Published:2018-12-27 Issue:2 Volume:30 Page:144-149
ISSN:0956-5507
Container-title:Cytopathology
language:en
Short-container-title:Cytopathology

Author:

Kawahara Akihiko¹^ORCID,Abe Hideyuki¹,Murata Kazuya¹,Ishii Hidenobu²,Azuma Koichi²,Takase Yorihiko¹,Hattori Satoshi³,Naito Yoshiki¹^ORCID,Akiba Jun¹

Affiliation:

1. Department of Diagnostic Pathology Kurume University Hospital Kurume Japan

2. Division of Respirology, Neurology, and Rheumatology Department of Internal Medicine Kurume University School of Medicine Kurume Japan

3. Department of Integrated Medicine Biomedical Statistics Osaka University Graduate School of Medicine Osaka Japan

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cyt.12660

Reference25 articles.

1. EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

2. Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial

3. Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors

4. Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Lung Cancer: Distinct Natural History of Patients with Tumors Harboring the T790M Mutation

5. Targeting the Gatekeeper: Osimertinib in EGFR T790M Mutation–Positive Non–Small Cell Lung Cancer

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in diagnostic liquid‐based cytology;Cytopathology;2024-06-04

2. Cerebrospinal fluid: A unique source of circulating tumor DNA with broad clinical applications;Translational Oncology;2023-07

3. KRASMutation Analysis Using Cell-free DNA of Pancreatic Cancer;Anticancer Research;2023-05-29

4. When Tissue Is the Issue;Clinics in Laboratory Medicine;2022-09

5. Cerebrospinal fluid as a medium of liquid biopsy in the management of patients with non-small-cell lung cancer having central nervous system metastasis;Frontiers in Bioscience-Landmark;2021-12-30